Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

soft tissue lymphoma versus soft tissue tumor

Soft tissue lymphomas versus soft tissue tumors: MRI features reliably differentiate between the two

A new analysis offers a detailed comparison of soft-tissue lymphomas and soft-tissue tumors based on imaging characteristics from MRI scans—an area of study that has not yet been rigorously explored, the authors of the paper indicated.

September 8, 2022

Photon-counting CT/AI combo improves multiple myeloma detection

When combined with artificial intelligence-based noise reduction techniques, new photon-counting CT technology can increase the detection of bone disease while also decreasing radiation exposure. 

September 8, 2022
The American College of Cardiology and American Heart Association have collaborated on a new update to the much-discussed 2021 chest pain guidelines. The American College of Emergency Physicians and Society for Cardiac Angiography and Interventions also contributed to the document.

New analysis highlights effectiveness of low-dose CT lung cancer screening

While the incidence of lung cancer did not significantly differ from start to finish, stage-specific incidence did.

September 7, 2022
bone and soft tissue tumors

Radiologists' understanding of tumor 'mimics' vital when assessing bone and soft tissue lesions

Authors of the new EJR paper explained that, although most of these tumors present in a similar way—with a lump or localized pain—their origins are wide-ranging and require the use of additional imaging to characterize the lesion. 

September 7, 2022
Surveillance breast MRI

Surveillance breast MRI findings linked with future second cancer

The new research focused specifically on associations between background parenchymal enhancement—a known risk factor for breast cancer, visualized on surveillance MRI exams—and secondary breast cancers.

August 30, 2022
Two examples of PSMA-PET scans showing numerous prostate cancer metastases spread throughout the body. Many of these smaller tumors would not have been detected on previous standard-of-care imaging. Photo on left courtesy of SNMMI, right University of Chicago. #PSMAPET

PSMA-PET is rapidly changing the standard of care for prostate cancer patients

Adoption of PSMA-PET has been swift because it can significantly improve prostate cancer detection and treatment. SNMMI President Munir Ghesani, MD, explains how.

August 26, 2022
breast cancer mammography mammogram

MR-directed enhanced mammography detects more malignancies than MR-directed ultrasound

MRI-directed contrast enhanced mammography could serve as a useful stand-alone or complimentary tool for biopsy planning when suspicious lesions are detected. 

August 25, 2022
Munir Ghesani, MD, SNMMI president, explained the impact of PSMA-PET imaging on nuclear image and treatment for prostate cancer.

VIDEO: Advantages of PSMA-PET imaging in prostate cancer care

Munir Ghesani, MD, president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and system chief of nuclear medicine at Mount Sinai Health, explains PSMA-PET has seen rapid adoption because it can significantly improve prostate cancer detection and treatment. 
 

August 25, 2022

Around the web

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

Trimed Popup
Trimed Popup